Dosimetric Comparisons of Three-dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, and Helical Tomotherapy in Whole Abdominopelvic Radiotherapy for Gynecologic Malignancy

被引:11
作者
Kim, Yong Bae [1 ]
Kim, Joo Ho [1 ]
Jeong, Kyung Keun [1 ]
Seong, Jinsil [1 ]
Suh, Chang Ok [1 ]
Kim, Gwi Eon [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Radiat Oncol, Yonsei Canc Ctr,Brain Korea Project Med Sci 21, Seoul, South Korea
关键词
Helical tomotherapy; Whole abdominopelvic radiotherapy; Gynecologic cancer; Bone marrow; EPITHELIAL OVARIAN-CARCINOMA; ACUTE HEMATOLOGIC TOXICITY; RADIATION-THERAPY; ABDOMINAL RADIOTHERAPY; EXTENDED-FIELD; STAGE-I; ABDOMEN IRRADIATION; PLUS CYCLOPHOSPHAMIDE; CONCURRENT CISPLATIN; CERVICAL-CANCER;
D O I
10.1177/153303460900800507
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. The goal of this study was to dosimetrically compare 3-dimensional radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), and helical tomotherapy (TOMO) plans for whole abdominopelvic radiotherapy (WART) in patients with gynecologic cancer. Methods. Ten patients were selected for WART planning. Doses were prescribed to planning target volumes (PTVs) as the followings: 30 Gy to PTV-whole abdominopelvis (PTV-WA), 40 Gy to PTV-para-aortic lymph node (PTV-PALN), 44 Gy to PTV-pelvis, and 50 Gy to gross target volume (GTV) in 20 fractions. Dose to whole liver, both kidneys, and spinal cord were constrained below each tissue tolerance, and bone marrow (BM)-sparing technique was adopted in IMRT and TOMO. Dosimetric parameters and treatment times were compared among plans. Results. Calculated doses in TOMO came most closely to the prescribed dose for coverage of PTV-WA, PTV-PALN, PTV-pelvis, and GTV compared to 3DCRT, and IMRT. In normal organs, TOMO had significantly better dosimetric profiles compared to IMRT and 3DCRT. TOMO significantly reduced V-20Gy, and mean dose of whole liver, both kidneys, and spinal cord. The use of BM-sparing technique (BMS) did not impair coverage of target volume in IMRT and TOMO. While IMRT showed no differences of irradiated BM dose using BMS, TOMO with BMS reduced half V-20Gy of BM compared to TOMO without BMS, Conclusions. TOMO showed dosimetric superiority in target coverage, sparing BM, and other normal organs compared to 3DCRT and IMRT. Clinical experiences will be needed for evaluation of feasibility of WART using TOMO in patients with gynecologic cancer.
引用
收藏
页码:369 / 377
页数:9
相关论文
共 26 条
[1]   Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer [J].
Beriwal, Sushil ;
Gan, Gregory N. ;
Heron, Dwight E. ;
Selvaraj, Rai N. ;
Kim, Hayeon ;
Lalonde, Ron ;
Kelley, Joseph L. ;
Edwards, Robert P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01) :166-171
[2]   Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies [J].
Brixey, CJ ;
Roeske, JC ;
Lujan, AE ;
Yamada, SD ;
Rotmensch, J ;
Mundt, AJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05) :1388-1396
[3]   TREATMENT OF EPITHELIAL CARCINOMA OF OVARY - OPERATION, IRRADIATION, AND CHEMOTHERAPY [J].
BUSH, RS ;
ALLT, WEC ;
BEALE, FA ;
BEAN, H ;
PRINGLE, JF ;
STURGEON, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1977, 127 (07) :692-704
[4]   Integrating radiation therapy in the curative management of ovarian cancer: Current issues and future directions [J].
Cardenes, H ;
Randall, ME .
SEMINARS IN RADIATION ONCOLOGY, 2000, 10 (01) :61-70
[5]   HIGH-RISK EARLY-STAGE OVARIAN-CANCER - RANDOMIZED CLINICAL-TRIAL COMPARING CISPLATIN PLUS CYCLOPHOSPHAMIDE VERSUS WHOLE ABDOMINAL RADIOTHERAPY [J].
CHIARA, S ;
CONTE, P ;
FRANZONE, P ;
ORSATTI, M ;
BRUZZONE, M ;
RUBAGOTTI, A ;
ODICINO, F ;
RUGIATI, S ;
CARNINO, F ;
ROSSO, R ;
RAGNI, N .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (01) :72-76
[6]  
DEMBO AJ, 1979, CANCER TREAT REP, V63, P249
[7]  
DEMBO AJ, 1984, SEMIN ONCOL, V11, P238
[8]  
FAJARDO LF, 2001, RAD PATHOLOGY, V36, P379
[9]   ANALYSIS OF POSTOPERATIVE RADIATION-THERAPY IN STAGE-I THROUGH STAGE-III EPITHELIAL OVARIAN-CARCINOMA [J].
FULLER, DB ;
SAUSE, WT ;
PLENK, HP ;
MENLOVE, RL .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) :897-905
[10]   Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix [J].
Gerszten, Kristina ;
Colonello, Kelly ;
Heron, Dwight E. ;
Lalonde, Ron J. ;
Fitian, Issa D. ;
Comerci, John T. ;
Selvaraj, Raj N. ;
Varlotto, John M. .
GYNECOLOGIC ONCOLOGY, 2006, 102 (02) :182-188